The first model of genetically engineered hypertension, the transgenic
rat TGR (mREN2)27, provides a unique opportunity to study the behavio
ural effects of an altered brain renin-angiotensin system. The TGR (mR
EN2)27 rats, characterised by fulminant hypertension, show differences
in both the peripheral and central angiotensin systems. The behaviour
of male transgenic TGR (mREN2)27 and male Sprague-Dawley rats were de
termined by 4 behavioural tests. While on the elevated X-maze the TGR
(mREN2)27 rat showed a greater 'anxiogenic' profile (fewer open arm en
tries) than the control Sprague-Dawley rats, this 'anxiogenic' profile
increased further during a second exposure to the elevated X-maze 24
h later. in comparison the behaviour of the male Sprague-Dawley rats w
as not different between the two exposures to the elevated X-maze. Loc
omotor activity did not differ between either the TGR (mREN2)27 or Spr
ague-Dawley rats when placed in a 1 m(2) open-field for 10 min. A shor
t period of fluid-deprivation (3 h) reversed the 'anxiogenic' profile
of the TGR (mREN2)27 on the elevated X-maze. Administration of captopr
il (20 mg . kg(-1) body weight) in the drinking water of the TGR (mREN
2)27 rats and Sprague-Dawley rats reversed the anxiogenic profile of t
he TGR (mREN2)27 rat on the elevated X-maze but did not alter the beha
viour of the Sprague:Dawley rats.